Is Vantive US Healthcare LLC FDA approved?

Vantive US Healthcare LLC holds 4 FDA-registered establishments across 4 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Vantive US Healthcare LLC's drugs manufactured?

At registered sites in the United Kingdom, Ireland, Italy, Mexico. The FDA register lists Liverpool; Castlebar; Sondalo; Jiutepec. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, sterilize.

What drugs does Vantive US Healthcare LLC make?

47 products are listed under Vantive US Healthcare LLC in the openFDA NDC Directory, most often as injection, solution; injection; powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Vantive US Healthcare LLC

Data as of 28 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 4
Active NDC listings: 44
Live patents: 0
Shortage listings: 18
Countries: 4
Base: Mexico

Authorisation

Registered operations

Analytical testing3Active ingredient (API) manufacture3Labelling3Finished drug manufacture3Packaging3sterilize3

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Vantive LimitedRegistrant: Vantive US Healthcare LLC	2 Wavertree Boulevard, Liverpool, L7 9PE, United Kingdom (GBR)	Active ingredient (API) manufacture	1000358697211243165
VANTIVE MANUFACTURING LIMITEDRegistrant: Vantive US Healthcare LLC	Moneen Road, Castlebar, County Mayo F23 XR63, Ireland (IRL)	Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, sterilize	0000000405986154341
Bieffe Medital S.p.A.Registrant: Vantive US Healthcare LLC	Via Stelvio 94, Sondalo, Sondrio 23035, Italy (ITA)	Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize	3003591774437668413
Baxter, S.A. de C.V.Registrant: Vantive US Healthcare LLC	Av. de Los 50 Metros No. 2, Jiutepec, Morelos 62578, Mexico (MEX)	Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, sterilize	0000006898810432484

Alert

Drug shortage listings

Drug	Presentation	Status	Availability	Posted / updated
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0427-53)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0457-05)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0411-07)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0429-53)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0415-06)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0413-06)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0413-07)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0426-53)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0433-51)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0424-51)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0429-52)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0430-51)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0426-52)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0427-52)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0459-05)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0409-07)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0415-07)	To Be Discontinued	-	3 Aug 20263 Aug 2026
Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, SolutionRenal	DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0411-06)	To Be Discontinued	-	3 Aug 20263 Aug 2026

Catalogue

Drug listings by form and route

44 active NDC listings: 43 human prescription drug, 1 bulk ingredient. By marketing category: NDA 25, UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE 18, BULK INGREDIENT 1.

Dosage form	NDCs
injection, solution	34
injection	9
powder	1

Route	NDCs
intraperitoneal	34
intravenous	9

Labeller name on the listing	NDCs
vantive us healthcare llc	44

Catalogue

Marketed products

Showing 44 of 47.

Brand	Generic name	Form / route	NDC
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0684UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0686UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0688UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0692UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0696UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0701UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0703UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0705UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0711UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0713UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0727UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0729UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0731UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0733UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL LOW CALCIUM WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0735UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL Low Calcium with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0409NDA
DIANEAL Low Calcium with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0424NDA
DIANEAL Low Calcium with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0430NDA
DIANEAL Low Calcium with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0433NDA
DIANEAL Low Calcium with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0457NDA
DIANEAL Low Calcium with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0459NDA
DIANEAL Low Calcium with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0484NDA
DIANEAL Low Calcium with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0487NDA
DIANEAL Low Calcium with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0490NDA
DIANEAL PD-2 WITH DEXTROSE	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0698UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
DIANEAL PD-2 with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0411NDA
DIANEAL PD-2 with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0413NDA
DIANEAL PD-2 with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0415NDA
DIANEAL PD-2 with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0426NDA
DIANEAL PD-2 with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0427NDA
DIANEAL PD-2 with Dextrose	sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	injection, solution, intraperitoneal	0941-0429NDA
EXTRANEAL	icodextrin, sodium chloride, sodium lactate, calcium chloride, magnesium chloride	injection, solution, intraperitoneal	0941-0679NDA
EXTRANEAL	icodextrin, sodium chloride, sodium lactate, calcium chloride, magnesium chloride	injection, solution, intraperitoneal	0941-0681UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
EXTRANEAL	icodextrin, sodium chloride, sodium lactate, calcium chloride, magnesium chloride	injection, solution, intraperitoneal	0941-0707UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
PHOXILLUM B22K4/0	magnesium chloride, sodium chloride, sodium bicarbonate, potassium chloride, and sodium phosphate dibasic dihydrate	injection, intravenous	24571-117NDA
PHOXILLUM BK4/2.5	calcium chloride, magnesium chloride, sodium chloride, sodium bicarbonate, potassium chloride, and sodium phosphate dibasic dihydrate	injection, intravenous	24571-116NDA
PRISMASOL B22GK4/0	magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride	injection, intravenous	24571-111NDA
PRISMASOL BGK0/2.5	calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, and sodium bicarbonate	injection, intravenous	24571-108NDA
PRISMASOL BGK2/0	magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride	injection, intravenous	24571-102NDA
PRISMASOL BGK2/3.5	calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride	injection, intravenous	24571-103NDA
PRISMASOL BGK4/0/1.2	magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride	injection, intravenous	24571-114NDA
PRISMASOL BGK4/2.5	calcium chloride, magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride	injection, intravenous	24571-105NDA
PRISMASOL BK0/0/1.2	magnesium chloride, lactic acid, sodium chloride, and sodium bicarbonate	injection, intravenous	24571-113NDA
-	icodextrin	powder	66127-100BULK INGREDIENT

Neighbours

Registered in the same town

AstraZeneca PLCLiverpool, GBR
Seqirus, Inc.Liverpool, GBR
Ames Goldsmith CorpLIVERPOOL, GBR
Degasa, S.A. de C.V.Jiutepec, MEX
Laboratorios Imperiales, S.A. de C.V.Jiutepec, MEX
SINTENOVO SA DE CVJiutepec, MEX

Compare

Comparable companies in Mexico

Symrise, Inc.5 sites · 28 NDC
Schwabe Mexico, S.A. de C.V.1 site · 28 NDC
Sicor de Mexico S.A. de C.V.1 site · 27 NDC
Avon Cosmetics Manufacturing, S. de R.L. de C.V.1 site · 16 NDC
Holiday Labs Mexico, S.A. de C.V.1 site · 15 NDC
Interquim, S.A. de C.V.1 site · 14 NDC
Nartex Laboratorios Homeopaticos, S.A. de C.V.1 site · 14 NDC
Degasa, S.A. de C.V.1 site · 11 NDC
Aqua Medica, S.A. de C.V.1 site · 10 NDC
Bayer de Mexico, S.A. de C.V.1 site · 10 NDC

Enquiry

Common questions

Is Vantive US Healthcare LLC FDA approved?: Vantive US Healthcare LLC holds 4 FDA-registered establishments across 4 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Vantive US Healthcare LLC's drugs manufactured?: At registered sites in the United Kingdom, Ireland, Italy, Mexico. The FDA register lists Liverpool; Castlebar; Sondalo; Jiutepec. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, sterilize.
What drugs does Vantive US Healthcare LLC make?: 47 products are listed under Vantive US Healthcare LLC in the openFDA NDC Directory, most often as injection, solution; injection; powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.